AAAAAA

   
Results: 1-15 |
Results: 15
PREVALENCE OF ANTIBODIES AGAINST VIRUS-LIKE PARTICLES OF EPIDERMODYSPLASIA VERRUCIFORMIS-ASSOCIATED HPV8 IN PATIENTS AT RISK OF SKIN-CANCER
Authors: STARK S PETRIDIS AK GHIM SJ JENSON AB BAVINCK JNB GROSS G STOCKFLETH E FUCHS PG PFISTER H
Citation: S. Stark et al., PREVALENCE OF ANTIBODIES AGAINST VIRUS-LIKE PARTICLES OF EPIDERMODYSPLASIA VERRUCIFORMIS-ASSOCIATED HPV8 IN PATIENTS AT RISK OF SKIN-CANCER, Journal of investigative dermatology, 111(4), 1998, pp. 696-701
GENITAL HPVS IN PREMALIGNANT AND MALIGNANT SKIN-LESIONS
Authors: MEYER T ARNDT R RAASCH I CHRISTOPHERS E STOCKFLETH E
Citation: T. Meyer et al., GENITAL HPVS IN PREMALIGNANT AND MALIGNANT SKIN-LESIONS, Journal of investigative dermatology, 110(4), 1998, pp. 668-668
SKIN TUMORS IN ORGAN TRANSPLANTED PATIENTS
Authors: STOCKFLETH E TEICHERT M HAAKE N HIRT S CHRISTOPHERS E MEYER T
Citation: E. Stockfleth et al., SKIN TUMORS IN ORGAN TRANSPLANTED PATIENTS, Journal of investigative dermatology, 110(4), 1998, pp. 670-670
A NEW OPTIMIZED TEST FOR 5-S-CYSTEINYLDOPA (5-S-CD) IN SERUM OF MELANOMA PATIENTS AS A MARKER OF TUMOR PROGRESSION
Authors: STOCKFLETH E DAMM Y HAUSCHILD A MEYER T ARNDT R CHRISTOPHERS E HARTLEB J
Citation: E. Stockfleth et al., A NEW OPTIMIZED TEST FOR 5-S-CYSTEINYLDOPA (5-S-CD) IN SERUM OF MELANOMA PATIENTS AS A MARKER OF TUMOR PROGRESSION, Journal of investigative dermatology, 110(4), 1998, pp. 717-717
AUTOANTIBODIES AGAINST P53 AND DR-70 IN SERUM ARE NO PROGNOSTIC MARKERS OF MALIGNANT-MELANOMA
Authors: DAMM Y HAUSCHILD A RADEMACHER O MEYER T CHRISTOPHERS E STOCKFLETH E
Citation: Y. Damm et al., AUTOANTIBODIES AGAINST P53 AND DR-70 IN SERUM ARE NO PROGNOSTIC MARKERS OF MALIGNANT-MELANOMA, Journal of investigative dermatology, 110(4), 1998, pp. 719-719
ASSOCIATION OF RARE HUMAN-PAPILLOMAVIRUS TYPES WITH GENITAL PREMALIGNANT AND MALIGNANT LESIONS
Authors: MEYER T ARNDT R CHRISTOPHERS E BECKMANN ER SCHRODER S GISSMANN L STOCKFLETH E
Citation: T. Meyer et al., ASSOCIATION OF RARE HUMAN-PAPILLOMAVIRUS TYPES WITH GENITAL PREMALIGNANT AND MALIGNANT LESIONS, The Journal of infectious diseases, 178(1), 1998, pp. 252-255
SOLUBLE CD44V6, CEA AND CA242 IN PREOPERATIVE SERA FROM PATIENTS WITHCOLORECTAL CARCINOMAS
Authors: FLAMMANN HT KUHN HM ARNDT R KEESER D WEINLAND G STOCKFLETH E FIBBE C LAYER P FRENZEL H
Citation: Ht. Flammann et al., SOLUBLE CD44V6, CEA AND CA242 IN PREOPERATIVE SERA FROM PATIENTS WITHCOLORECTAL CARCINOMAS, Gastroenterology, 114(4), 1998, pp. 2445-2445
SOLUBLE CD44V6 AND CA242 IN PREOPERATIVE SERA FROM PATIENTS WITH GASTRIC AND ESOPHAGUS CARCINOMAS
Authors: KUHN HM FLAMMANN HT KEESER D ARNDT R STOCKFLETH E WEINLAND G FIBBE C FRENZEL H LAYER P
Citation: Hm. Kuhn et al., SOLUBLE CD44V6 AND CA242 IN PREOPERATIVE SERA FROM PATIENTS WITH GASTRIC AND ESOPHAGUS CARCINOMAS, Gastroenterology, 114(4), 1998, pp. 2592-2592
MALIGNANT-MELANOMA - HOW USEFUL ARE TUMOR-MARKERS IN THE DETECTION OFHEMATOGENOUS METASTASIS
Authors: HAUSCHILD A STOCKFLETH E GLASER R CHRISTOPHERS E
Citation: A. Hauschild et al., MALIGNANT-MELANOMA - HOW USEFUL ARE TUMOR-MARKERS IN THE DETECTION OFHEMATOGENOUS METASTASIS, British Journal of Cancer, 77, 1998, pp. 74-74
OPTIMIZED DETECTION OF 5-S-CYSTEINYLDOPA (5-S-CD) IN SERUM OF MELANOMA PATIENTS - A NEW MARKER OF METASTATIC MELANOMA
Authors: STOCKFLETH E HARTLEB J MEYER T HECKMANN O ARNDT R CHRISTOPHERS E HAUSCHILD A
Citation: E. Stockfleth et al., OPTIMIZED DETECTION OF 5-S-CYSTEINYLDOPA (5-S-CD) IN SERUM OF MELANOMA PATIENTS - A NEW MARKER OF METASTATIC MELANOMA, European journal of cancer, 33, 1997, pp. 1162-1162
SKIN CHANGES IN SUCCESSFULLY TREATED HODGKINS-DISEASE PATIENTS
Authors: STOCKFLETH E FLAMMANN HT MEYER T PFISTER H HOSSFELD DK CHRISTOPHERS E
Citation: E. Stockfleth et al., SKIN CHANGES IN SUCCESSFULLY TREATED HODGKINS-DISEASE PATIENTS, European journal of cancer, 33, 1997, pp. 1191-1191
HUMAN-PAPILLOMAVIRUS DISTRIBUTION IN CERVICAL TISSUES OF DIFFERENT MORPHOLOGY AS DETERMINED BY HYBRID CAPTURE ASSAY AND PCR
Authors: NINDL I GREINKE C ZAHM DM STOCKFLETH E HOYER H SCHNEIDER A
Citation: I. Nindl et al., HUMAN-PAPILLOMAVIRUS DISTRIBUTION IN CERVICAL TISSUES OF DIFFERENT MORPHOLOGY AS DETERMINED BY HYBRID CAPTURE ASSAY AND PCR, International journal of gynecological pathology, 16(3), 1997, pp. 197-204
THE ASSOCIATION OF HUMAN PAPILLOMAVIRUS TYPE-16 E6 AND E7 ANTIBODIES WITH STAGE OF CERVICAL-CANCER
Authors: FISHER SG BENITEZBRIBIESCA L NINDL I STOCKFLETH E MULLER M WOLF H PEREZGARCIA F GUZMANGAONA J GUTIERREZDELGADO F IRVIN W GISSMANN L
Citation: Sg. Fisher et al., THE ASSOCIATION OF HUMAN PAPILLOMAVIRUS TYPE-16 E6 AND E7 ANTIBODIES WITH STAGE OF CERVICAL-CANCER, Gynecologic oncology, 61(1), 1996, pp. 73-78
HUMAN PAPILLOMAVIRUS INFECTION (HPV) IN CURED HODGKINS-DISEASE PATIENTS
Authors: STOCKFLETH E STEGER G PFISTER H GROSS G HECKMANN O GISSMANN L CHRISTOPHERS E
Citation: E. Stockfleth et al., HUMAN PAPILLOMAVIRUS INFECTION (HPV) IN CURED HODGKINS-DISEASE PATIENTS, Journal of investigative dermatology, 107(3), 1996, pp. 351-351
STRATEGY FOR TYPING HUMAN PAPILLOMAVIRUSES BY RFLP ANALYSIS OF PCR PRODUCTS AND SUBSEQUENT HYBRIDIZATION WITH A GENERIC PROBE
Authors: MEYER T ARNDT R STOCKFLETH E FLAMMANN HT WOLF H REISCHL U
Citation: T. Meyer et al., STRATEGY FOR TYPING HUMAN PAPILLOMAVIRUSES BY RFLP ANALYSIS OF PCR PRODUCTS AND SUBSEQUENT HYBRIDIZATION WITH A GENERIC PROBE, BioTechniques, 19(4), 1995, pp. 632
Risultati: 1-15 |